Fresenius SE KGaA (Fresenius SE KGaA) Change In Receivables : $-273 Mil (TTM As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Fresenius SE KGaA Change In Receivables?

Fresenius SE KGaA's change in receivables for the quarter that ended in Dec. 2023 was $458 Mil. It means Fresenius SE KGaA's Accounts Receivable declined by $458 Mil from Sep. 2023 to Dec. 2023 .

Fresenius SE KGaA's change in receivables for the fiscal year that ended in Dec. 2023 was $-288 Mil. It means Fresenius SE KGaA's Accounts Receivable increased by $288 Mil from Dec. 2022 to Dec. 2023 .

Fresenius SE KGaA's Accounts Receivable for the quarter that ended in Dec. 2023 was $4,005 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Fresenius SE KGaA's Days Sales Outstanding for the three months ended in Dec. 2023 was 59.03.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Fresenius SE KGaA's liquidation value for the three months ended in Dec. 2023 was $-21,080 Mil.

Fresenius SE KGaA Change In Receivables Historical Data

The historical data trend for Fresenius SE KGaA's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Change In Receivables Chart

Fresenius SE KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-680.00

-31.63

98.31

171.61

-287.90

Fresenius SE KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															702.33	-910.06	159.26	20.28	458.02

Fresenius SE KGaA Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-273 Mil.

Fresenius SE KGaA (OTCPK:FSNUY) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Fresenius SE KGaA's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4005.453	/	6191.93	*	91
=	59.03

2. In Ben Graham's calculation of liquidation value, Fresenius SE KGaA's accounts receivable are only considered to be worth 75% of book value:

Fresenius SE KGaA's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2496.183	-	27953.108	+	0.75 * 4005.453	+	0.5 * 2744.82
=	-21,080

Fresenius SE KGaA Change In Receivables Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius SE KGaA (Fresenius SE KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (OTCPK:FSNUY) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

FSNUF:USA FREN:Mexico FRE:Italy FREd:UK 0OO9:UK FRE:Germany FRE:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.fresenius.com

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Fresenius SE KGaA (Fresenius SE KGaA) Headlines

From GuruFocus

Tweedy Brown Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood • 05-04-2021

Fresenius SE KGaA Stock Is Estimated To Be Fairly Valued

By GF Value • 07-02-2021

Fresenius SE KGaA Stock Is Believed To Be Modestly Undervalued

By GF Value GF Value • 04-01-2021

Tweedy Browne Fund's 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood • 05-04-2021

Top 1st-Quarter Trades of the Tweedy Browne Global Value Fund

By Margaret Moran Margaret Moran • 04-13-2021

Fresenius SE & Co. KGaA to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 13 November 2019

By PRNewswire PRNewswire • 11-07-2019

Tweedy Browne Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood • 06-01-2021